Serologic Testing in Primary Syphilis

Understanding the Serologic Window Period

Treponemal antibodies typically appear 1-4 weeks after infection, while nontreponemal antibodies (RPR) appear slightly later but are reliably positive by 4-6 weeks in primary syphilis, according to the Centers for Disease Control and Prevention (CDC) guidelines 1
The sensitivity of RPR in primary syphilis is only 88.5%, meaning approximately 11-12% of primary cases will have negative RPR results, as reported by the CDC 2

If clinical suspicion for primary syphilis is high despite negative serology, darkfield microscopy or direct fluorescent antibody (DFA) testing of the chancre exudate provides definitive diagnosis without waiting for antibody development, as recommended by the CDC 3
Repeat serologic testing in 1-2 weeks is essential, as most patients will seroconvert by 4-6 weeks after chancre onset, according to the Infectious Diseases Society of America (IDSA) guidelines 1

The CDC recommends empirical treatment with benzathine penicillin G 2.4 million units IM as a single dose for suspected primary syphilis, especially in high-risk patients or those likely to be lost to follow-up, based on guidelines from the CDC 2

Always pursue direct detection methods (darkfield, DFA, or PCR) when a suspicious lesion is present, rather than relying on serology alone in early infection, as recommended by the CDC and the American Sexual Health Association (ASHA) 3, 4

For patients with suspected early syphilis infection, order both treponemal (e.g., FTA‑ABS, TP‑PA, EIA/CLIA) and nontreponemal (e.g., RPR, VDRL) serologic tests at the same visit to ensure the highest likelihood of detection during the early window period. [5][6]